Anthony D Cristillo

Summary

Affiliation: Advanced BioScience Laboratories
Country: USA

Publications

  1. ncbi A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes
    Alagarsamy Srinivasan
    Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Virol J 5:99. 2008
  2. ncbi Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine
    Anthony D Cristillo
    Advanced BioScience Laboratories, Department of Cell Biology, 5510 Nicholson Lane, Kensington, MD 20895, USA
    Virology 346:151-68. 2006
  3. ncbi HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3
    Anthony D Cristillo
    Advanced BioScience Laboratories, Inc, 5510 Nicholson Lane, Kensington, MD 20895, USA
    Virology 366:197-211. 2007
  4. ncbi HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat
    Anthony D Cristillo
    Advanced BioScience Laboratories, Inc, 5510 Nicholson Lane, Kensington, MD 20895, USA
    Biochem Biophys Res Commun 370:22-6. 2008
  5. ncbi Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
    Anthony D Cristillo
    Advanced BioScience Laboratories Inc, 5510 Nicholson Lane, Kensington, MD 20895, USA
    J Gen Virol 92:128-40. 2011
  6. ncbi Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
    Susan W Barnett
    Novartis Vaccines and Diagnostics, Inc, 4560 Horton Street, Emeryville, California 94608, USA
    AIDS 22:339-48. 2008
  7. ncbi Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation
    Anthony D Cristillo
    Advanced BioScience Laboratories, Inc, Department of Cell Biology, 5510 Nicholson Lane, Kensington, MD 20895, USA
    Biochem Biophys Res Commun 366:29-35. 2008
  8. ncbi Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity
    Bo Peng
    Vaccine Branch, Center for Cancer Research, National Cancer Institute, 41 Medlars Drive, Bethesda, MD 20892, USA
    AIDS 20:2149-57. 2006
  9. ncbi Differences between CEM and human peripheral blood T lymphocytes in cAMP-dependent HIV viral fusion and CXCR4 expression
    Anthony D Cristillo
    Laboratory of Lymphocyte Biology, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland 20892, USA
    Exp Mol Pathol 73:9-18. 2002
  10. ncbi Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element
    Anthony D Cristillo
    Laboratory of Lymphocyte Biology, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA
    FASEB J 16:354-64. 2002

Collaborators

Detail Information

Publications10

  1. ncbi A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes
    Alagarsamy Srinivasan
    Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Virol J 5:99. 2008
    ..The available data on naturally occurring polymorphisms will be useful to assess their potential effect on the structural and functional constraints of Vpr and also on the fitness of HIV-1 for replication...
  2. ncbi Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine
    Anthony D Cristillo
    Advanced BioScience Laboratories, Department of Cell Biology, 5510 Nicholson Lane, Kensington, MD 20895, USA
    Virology 346:151-68. 2006
    ....
  3. ncbi HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3
    Anthony D Cristillo
    Advanced BioScience Laboratories, Inc, 5510 Nicholson Lane, Kensington, MD 20895, USA
    Virology 366:197-211. 2007
    ..Overall, the topical DermaVir/protein vaccination yields central memory T cell responses and facilitates control of pathogenic SHIV infection...
  4. ncbi HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat
    Anthony D Cristillo
    Advanced BioScience Laboratories, Inc, 5510 Nicholson Lane, Kensington, MD 20895, USA
    Biochem Biophys Res Commun 370:22-6. 2008
    ..Induction of CD8(+) and CD4(+) T cells and functional CTL activity was noted. These results highlight the potential use of orally administered Talabostat for efficient protein boosting of antibody and T-cell responses primed by DNA...
  5. ncbi Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
    Anthony D Cristillo
    Advanced BioScience Laboratories Inc, 5510 Nicholson Lane, Kensington, MD 20895, USA
    J Gen Virol 92:128-40. 2011
    ....
  6. ncbi Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope
    Susan W Barnett
    Novartis Vaccines and Diagnostics, Inc, 4560 Horton Street, Emeryville, California 94608, USA
    AIDS 22:339-48. 2008
    ..Worldwide, the majority of human immunodeficiency virus (HIV) infections occur by heterosexual transmission. Thus, the development of a vaccine that can prevent intravaginal HIV infection is an important goal of AIDS vaccine research...
  7. ncbi Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation
    Anthony D Cristillo
    Advanced BioScience Laboratories, Inc, Department of Cell Biology, 5510 Nicholson Lane, Kensington, MD 20895, USA
    Biochem Biophys Res Commun 366:29-35. 2008
    ..These findings highlight efficient priming of immune responses by electroporated DNA that in conjunction with protein boost may give rise to long-term immunity in immunized hosts...
  8. ncbi Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity
    Bo Peng
    Vaccine Branch, Center for Cancer Research, National Cancer Institute, 41 Medlars Drive, Bethesda, MD 20892, USA
    AIDS 20:2149-57. 2006
    ..To determine if immunization with non-myristoylated nef would elicit enhanced cellular immune responses resulting from improved presentation of Nef peptides by MHC-I on the cell surface, and enhanced T-cell help...
  9. ncbi Differences between CEM and human peripheral blood T lymphocytes in cAMP-dependent HIV viral fusion and CXCR4 expression
    Anthony D Cristillo
    Laboratory of Lymphocyte Biology, National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland 20892, USA
    Exp Mol Pathol 73:9-18. 2002
    ..Moreover, our results suggest that, for CXCR4 expression and HIV viral infectivity, CEM cells may not be a faithful model of primary human lymphocytes...
  10. ncbi Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element
    Anthony D Cristillo
    Laboratory of Lymphocyte Biology, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA
    FASEB J 16:354-64. 2002
    ..The cAMP-dependent up-regulation of CXCR4 mRNA results in increased CXCR4 intracellular and cell surface protein expression as well as increased HIV infectivity...